|
This program provides brand name medications at no or low cost.
|
| Pharmaceutical Company |
Novartis Pharmaceuticals |
| Program Name |
Novartis Oncology Patient Assistance Program |
| Program Address |
Novartis Patient Assistance Program
PO Box 66556
St. Louis, MO 63166-6556
|
| Phone Number |
866-884-5906
|
| Fax Number |
|
| Medications on Program |
Afinitor Tablets 5mg, 10mg (everolimus)
Femara Tablets 2.5mg (letrozole)
Gleevec Tablets 100mg, 400mg (imatinib)
Sandostatin LAR Depot For Injectable Solution 10mg (oclerolide)
Sandostatin LAR Depot for Injection 20mg, 30mg (octreotide)
Tasigna Tablets 200mg (nilotinib)
Zometa Injection 4mg (zoledronic acid)
|
| Application Forms |
Novartis Oncology Patient Assistance Program
|
On-line Application
|
No on-line application available at this time |
| Web Site |
Click to go to program's web site |
| Eligibility Guidelines and Notes |
The patient can have no public or private prescription insurance and must meet income eligibility criteria which vary by household size. Medical diagnosis necessary for this program is not specified. The patient must also be a US resident. Patient applications are evaluated on a case by case basis. Medicare beneficiaries who enroll in a Part D plan, may be considered for the Novartis PAP on an exception basis.
|
| Application Process |
The physician needs to start the process by asking for a service request.
|
| Application Requirements |
Not applicable.
|
| Program Details |
The medication is sent to either the doctor's office or the patient's home.
|
| Last Updated |
April 14, 2010 |
